ArticleInternational journal of microbiology2025
Detection and Antimicrobial Susceptibility of Carbapenem-Resistant Organisms Isolated in the Center of Care and Protection of Orphan Children, Vietnam.
Article in International journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Proposed Risk of Bias Assessment Tool forPathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbapenems are critical for treating patients infected with multidrug-resistant bacteria; however, the use of carbapenems has also facilitated the selection and spreading of carbapenem-resistant organisms (CROs), occasionally reported in healthcare settings. The study examined the CRO prevalence among healthcare workers (HCWs), orphan children patients, and the environment in an orphanage healthcare facility in Vietnam. A cross-sectional study was performed by collecting rectal swabs in 20 HCWs and 67 orphan patients, as well as in 175 randomly selected environmental samples. Chromogenic CARBA agars, blood agars, and a BD Phoenix Automated Microbiology System were employed for bacterial isolation and for identification and testing of antimicrobial susceptibility. In a total of 262 samples, 36 CROs (i.e., six carbapenem-resistant Enterobacterales [CRE] and 30 non-CRE) were detected. The CRO prevalence of 30.0% (6/20), 16.4% (11/67), and 10.86% (19/175) was shown in HCWs, orphan patients, and the environment, respectively. Most CROs detected in HCWs were CREs (66.7%, 4/6). Non-CRE cases, mainly
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.